The same group demonstrated that overexpression of non-receptor tyrosine kinase Etk/BMX induced AR phosphorylation and castration resistance, suggesting that Etk/BMX is another tyrosine kinase of AR associated with castration-resistant progression of prostate cancer [97]. Here, AR is linked to prostate carcinoma.